 Krithika Lingappan
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 11 | 2026 | 107 | 4.700 |
Why?
| | Bronchopulmonary Dysplasia | 9 | 2026 | 420 | 3.510 |
Why?
| | Lung Injury | 5 | 2023 | 249 | 1.640 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2026 | 298 | 1.330 |
Why?
| | Laryngoscopy | 2 | 2023 | 121 | 1.170 |
Why?
| | Biomedical Research | 2 | 2025 | 719 | 1.120 |
Why?
| | Endothelial Cells | 3 | 2026 | 878 | 1.100 |
Why?
| | Neonatologists | 2 | 2025 | 11 | 1.080 |
Why?
| | Intubation, Intratracheal | 2 | 2023 | 327 | 1.030 |
Why?
| | Pulmonary Alveoli | 2 | 2026 | 387 | 0.910 |
Why?
| | Neonatology | 1 | 2025 | 33 | 0.860 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2025 | 148 | 0.840 |
Why?
| | Research Personnel | 1 | 2025 | 185 | 0.770 |
Why?
| | Animals, Newborn | 5 | 2026 | 896 | 0.720 |
Why?
| | Acute Lung Injury | 2 | 2017 | 307 | 0.720 |
Why?
| | Cytochrome P-450 CYP1A2 | 3 | 2023 | 7 | 0.700 |
Why?
| | Disease Models, Animal | 4 | 2026 | 4568 | 0.680 |
Why?
| | Ampicillin | 1 | 2019 | 17 | 0.610 |
Why?
| | Infant, Newborn | 12 | 2024 | 6465 | 0.590 |
Why?
| | Lung Diseases | 1 | 2025 | 782 | 0.560 |
Why?
| | beta-Naphthoflavone | 1 | 2017 | 2 | 0.540 |
Why?
| | Infant, Premature | 1 | 2022 | 620 | 0.530 |
Why?
| | Lung | 8 | 2026 | 4116 | 0.520 |
Why?
| | Botulism | 1 | 2016 | 9 | 0.480 |
Why?
| | Hypocapnia | 1 | 2016 | 9 | 0.480 |
Why?
| | Physicians | 1 | 2025 | 956 | 0.480 |
Why?
| | Mice, Inbred C57BL | 8 | 2026 | 5992 | 0.450 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2016 | 50 | 0.440 |
Why?
| | Sex Characteristics | 3 | 2018 | 789 | 0.440 |
Why?
| | Simulation Training | 1 | 2017 | 136 | 0.430 |
Why?
| | Oxygen | 2 | 2023 | 981 | 0.420 |
Why?
| | Pediatrics | 2 | 2023 | 1125 | 0.390 |
Why?
| | Oxygen Consumption | 1 | 2016 | 719 | 0.380 |
Why?
| | Mice | 10 | 2026 | 18355 | 0.370 |
Why?
| | Pulmonary Artery | 1 | 2018 | 1129 | 0.360 |
Why?
| | Female | 21 | 2026 | 79045 | 0.350 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2023 | 29 | 0.340 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 768 | 0.340 |
Why?
| | Animals | 12 | 2026 | 38101 | 0.330 |
Why?
| | Male | 17 | 2026 | 73010 | 0.290 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1925 | 0.280 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2026 | 655 | 0.270 |
Why?
| | Mice, Knockout | 4 | 2026 | 3130 | 0.270 |
Why?
| | Sex Factors | 3 | 2025 | 2110 | 0.260 |
Why?
| | Resuscitation | 2 | 2023 | 312 | 0.260 |
Why?
| | Humans | 22 | 2026 | 145783 | 0.260 |
Why?
| | Internship and Residency | 1 | 2017 | 1269 | 0.240 |
Why?
| | Neutrophil Infiltration | 3 | 2016 | 107 | 0.240 |
Why?
| | Uteroglobin | 1 | 2026 | 31 | 0.240 |
Why?
| | Cell Proliferation | 2 | 2026 | 2514 | 0.220 |
Why?
| | Research Support as Topic | 1 | 2025 | 81 | 0.220 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2024 | 67 | 0.200 |
Why?
| | Pregnancy | 5 | 2026 | 7216 | 0.190 |
Why?
| | Career Choice | 1 | 2025 | 235 | 0.190 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2023 | 293 | 0.190 |
Why?
| | Job Satisfaction | 1 | 2025 | 238 | 0.190 |
Why?
| | Oxidative Stress | 3 | 2021 | 1360 | 0.180 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2022 | 42 | 0.180 |
Why?
| | Gestational Age | 2 | 2023 | 990 | 0.180 |
Why?
| | Work Performance | 1 | 2022 | 8 | 0.180 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2021 | 37 | 0.170 |
Why?
| | Cytochrome P-450 CYP1A1 | 2 | 2023 | 11 | 0.170 |
Why?
| | Societies, Medical | 1 | 2025 | 900 | 0.160 |
Why?
| | Cardiac Catheterization | 1 | 2024 | 559 | 0.160 |
Why?
| | Wnt-5a Protein | 1 | 2020 | 25 | 0.160 |
Why?
| | Metabolome | 2 | 2021 | 391 | 0.160 |
Why?
| | Epigenomics | 1 | 2020 | 117 | 0.150 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 119 | 0.150 |
Why?
| | Workload | 1 | 2021 | 169 | 0.150 |
Why?
| | DNA Adducts | 1 | 2019 | 17 | 0.150 |
Why?
| | Environmental Pollution | 1 | 2019 | 21 | 0.150 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.140 |
Why?
| | United States | 3 | 2025 | 16126 | 0.140 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 219 | 0.140 |
Why?
| | Smoking | 1 | 2026 | 1477 | 0.140 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2018 | 50 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2026 | 920 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 212 | 0.130 |
Why?
| | Dysbiosis | 1 | 2019 | 188 | 0.130 |
Why?
| | Infant | 4 | 2024 | 10091 | 0.130 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 85 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2022 | 714 | 0.130 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2019 | 508 | 0.130 |
Why?
| | Transfection | 1 | 2019 | 927 | 0.130 |
Why?
| | Manikins | 1 | 2017 | 37 | 0.130 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 193 | 0.120 |
Why?
| | Dinoprost | 2 | 2015 | 51 | 0.120 |
Why?
| | Cell Culture Techniques | 1 | 2019 | 375 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 220 | 0.120 |
Why?
| | Muscle Hypotonia | 1 | 2016 | 34 | 0.120 |
Why?
| | Apgar Score | 1 | 2016 | 22 | 0.120 |
Why?
| | Blood Gas Analysis | 1 | 2016 | 82 | 0.120 |
Why?
| | Actins | 1 | 2018 | 426 | 0.120 |
Why?
| | Video Recording | 1 | 2017 | 219 | 0.120 |
Why?
| | Immunoglobulins | 1 | 2016 | 163 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 693 | 0.110 |
Why?
| | Time Factors | 2 | 2017 | 7134 | 0.110 |
Why?
| | Botulinum Toxins, Type A | 1 | 2016 | 60 | 0.110 |
Why?
| | Probability | 1 | 2016 | 308 | 0.110 |
Why?
| | Cell Survival | 1 | 2018 | 1104 | 0.110 |
Why?
| | Premature Birth | 1 | 2019 | 390 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 6085 | 0.110 |
Why?
| | Hypothermia, Induced | 1 | 2016 | 96 | 0.110 |
Why?
| | Cross-Over Studies | 1 | 2017 | 610 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 611 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 532 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1042 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 821 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 963 | 0.100 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 120 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 517 | 0.090 |
Why?
| | Fibroblasts | 1 | 2018 | 1028 | 0.090 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 339 | 0.090 |
Why?
| | Neurodevelopmental Disorders | 1 | 2016 | 229 | 0.090 |
Why?
| | Electroencephalography | 1 | 2016 | 563 | 0.090 |
Why?
| | NF-kappa B | 1 | 2016 | 667 | 0.090 |
Why?
| | Placenta | 1 | 2019 | 787 | 0.090 |
Why?
| | Heart Arrest | 1 | 2016 | 411 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1512 | 0.090 |
Why?
| | Seizures | 1 | 2016 | 485 | 0.090 |
Why?
| | Models, Statistical | 1 | 2016 | 672 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2017 | 11794 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1184 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2018 | 4151 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2015 | 780 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1723 | 0.070 |
Why?
| | Clinical Competence | 1 | 2017 | 1247 | 0.070 |
Why?
| | Cytokines | 1 | 2016 | 2069 | 0.070 |
Why?
| | Middle Aged | 3 | 2026 | 36309 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2933 | 0.070 |
Why?
| | Prognosis | 1 | 2016 | 4330 | 0.060 |
Why?
| | Adult | 3 | 2026 | 40881 | 0.060 |
Why?
| | Child | 2 | 2023 | 22740 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2444 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 6033 | 0.050 |
Why?
| | Child, Preschool | 1 | 2018 | 11868 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2023 | 162 | 0.050 |
Why?
| | Biomarkers | 1 | 2013 | 4302 | 0.040 |
Why?
| | Puerto Rico | 1 | 2021 | 63 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 648 | 0.040 |
Why?
| | Physicians, Women | 1 | 2021 | 90 | 0.040 |
Why?
| | Professional Role | 1 | 2021 | 170 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5925 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2022 | 305 | 0.030 |
Why?
| | Texas | 1 | 2019 | 273 | 0.030 |
Why?
| | Blood Pressure | 1 | 2024 | 1782 | 0.030 |
Why?
| | Risk Factors | 2 | 2023 | 10919 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2024 | 17330 | 0.030 |
Why?
| | F2-Isoprostanes | 1 | 2015 | 21 | 0.030 |
Why?
| | Malondialdehyde | 1 | 2015 | 31 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 168 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2015 | 318 | 0.030 |
Why?
| | Aldehydes | 1 | 2015 | 140 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1711 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2601 | 0.020 |
Why?
| | Neutrophils | 1 | 2015 | 1127 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8347 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8078 | 0.020 |
Why?
| | Liver | 1 | 2015 | 1899 | 0.010 |
Why?
| | Aged | 1 | 2021 | 26217 | 0.010 |
Why?
|
|
Lingappan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|